221 related articles for article (PubMed ID: 17254575)
41. HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells.
Muthumani K; Hwang DS; Desai BM; Zhang D; Dayes N; Green DR; Weiner DB
J Biol Chem; 2002 Oct; 277(40):37820-31. PubMed ID: 12095993
[TBL] [Abstract][Full Text] [Related]
42. Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR).
Schafer EA; Venkatachari NJ; Ayyavoo V
Antiviral Res; 2006 Dec; 72(3):224-32. PubMed ID: 16889838
[TBL] [Abstract][Full Text] [Related]
43. Virion-associated HIV-1 Vpr: variable amount in virus particles derived from cells upon virus infection or proviral DNA transfection.
Singh SP; Tungaturthi P; Cartas M; Tomkowicz B; Rizvi TA; Khan SA; Kalyanaraman VS; Srinivasan A
Virology; 2001 Apr; 283(1):78-83. PubMed ID: 11312664
[TBL] [Abstract][Full Text] [Related]
44. Cell cycle G2 arrest, cell death and nuclear localization induced by human immunodeficiency virus type 1 protein R (VPR) in cervical cancer cells.
Yang J; Yi Y; Wang J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):223-6, 301. PubMed ID: 11498683
[TBL] [Abstract][Full Text] [Related]
45. HIV-1 viral protein R (Vpr) induction of apoptosis and cell cycle arrest in multidrug-resistant colorectal cancer cells.
Ma B; Zhang H; Wang J; Zhang B; Xu X; Cheng B
Oncol Rep; 2012 Jul; 28(1):358-64. PubMed ID: 22552851
[TBL] [Abstract][Full Text] [Related]
46. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore.
Jacotot E; Ravagnan L; Loeffler M; Ferri KF; Vieira HL; Zamzami N; Costantini P; Druillennec S; Hoebeke J; Briand JP; Irinopoulou T; Daugas E; Susin SA; Cointe D; Xie ZH; Reed JC; Roques BP; Kroemer G
J Exp Med; 2000 Jan; 191(1):33-46. PubMed ID: 10620603
[TBL] [Abstract][Full Text] [Related]
47. Structural studies of synthetic peptide fragments derived from the HIV-1 Vpr protein.
Luo Z; Butcher DJ; Murali R; Srinivasan A; Huang Z
Biochem Biophys Res Commun; 1998 Mar; 244(3):732-6. PubMed ID: 9535734
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).
Gleenberg IO; Herschhorn A; Hizi A
J Mol Biol; 2007 Jun; 369(5):1230-43. PubMed ID: 17490682
[TBL] [Abstract][Full Text] [Related]
49. Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression.
Coiras M; Camafeita E; Ureña T; López JA; Caballero F; Fernández B; López-Huertas MR; Pérez-Olmeda M; Alcamí J
Proteomics; 2006 Apr; 6 Suppl 1():S63-73. PubMed ID: 16526095
[TBL] [Abstract][Full Text] [Related]
50. HIV-1 Viral protein-r (Vpr) protects against lethal superantigen challenge while maintaining homeostatic T cell levels in vivo.
Muthumani K; Choo AY; Hwang DS; Dayes NS; Chattergoon M; Mayilvahanan S; Thieu KP; Buckley PT; Emmanuel J; Premkumar A; Weiner DB
Mol Ther; 2005 Nov; 12(5):910-21. PubMed ID: 16006193
[TBL] [Abstract][Full Text] [Related]
51. Dual role of the HIV-1 vpr protein in the modulation of the apoptotic response of T cells.
Conti L; Matarrese P; Varano B; Gauzzi MC; Sato A; Malorni W; Belardelli F; Gessani S
J Immunol; 2000 Sep; 165(6):3293-300. PubMed ID: 10975846
[TBL] [Abstract][Full Text] [Related]
52. Vpr cytopathicity independent of G2/M cell cycle arrest in human immunodeficiency virus type 1-infected CD4+ T cells.
Bolton DL; Lenardo MJ
J Virol; 2007 Sep; 81(17):8878-90. PubMed ID: 17553871
[TBL] [Abstract][Full Text] [Related]
53. The C-terminal domain of the HIV-1 regulatory protein Vpr adopts an antiparallel dimeric structure in solution via its leucine-zipper-like domain.
Bourbigot S; Beltz H; Denis J; Morellet N; Roques BP; Mély Y; Bouaziz S
Biochem J; 2005 Apr; 387(Pt 2):333-41. PubMed ID: 15571493
[TBL] [Abstract][Full Text] [Related]
54. [Effects of different mutated sites in vpr gene of HIV on apoptosis of host cells: experiment with HeLa cells].
Zheng YH; Zhang CY; He Y; Gong GZ; Li H; Chen Z; Liu M; Zhou HY; Li Y; Liu C; Li J; Zhou GQ; Yin W; Yuan HL
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):614-9. PubMed ID: 19595162
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of Vpr-induced cell cycle abnormality by quercetin: a novel strategy for searching compounds targeting Vpr.
Shimura M; Zhou Y; Asada Y; Yoshikawa T; Hatake K; Takaku F; Ishizaka Y
Biochem Biophys Res Commun; 1999 Aug; 261(2):308-16. PubMed ID: 10425183
[TBL] [Abstract][Full Text] [Related]
56. Functional integrity of naturally occurring mutants of HIV-1 subtype C Vpr.
Romani B; Glashoff RH; Engelbrecht S
Virus Res; 2010 Nov; 153(2):288-98. PubMed ID: 20801175
[TBL] [Abstract][Full Text] [Related]
57. Alterations in the C-terminal region of the HIV-1 accessory gene vpr do not confer clinical advantage to subjects receiving nucleoside antiretroviral therapy.
Cavert W; Webb CH; Balfour HH
J Infect Dis; 2004 Jun; 189(12):2181-4. PubMed ID: 15181564
[TBL] [Abstract][Full Text] [Related]
58. HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT.
Andersen JL; DeHart JL; Zimmerman ES; Ardon O; Kim B; Jacquot G; Benichou S; Planelles V
PLoS Pathog; 2006 Dec; 2(12):e127. PubMed ID: 17140287
[TBL] [Abstract][Full Text] [Related]
59. An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization.
Modem S; Reddy TR
J Cell Physiol; 2008 Jan; 214(1):14-9. PubMed ID: 17929250
[TBL] [Abstract][Full Text] [Related]
60. Targeted Vpr-derived peptides reach mitochondria to induce apoptosis of alphaVbeta3-expressing endothelial cells.
Borgne-Sanchez A; Dupont S; Langonné A; Baux L; Lecoeur H; Chauvier D; Lassalle M; Déas O; Brière JJ; Brabant M; Roux P; Péchoux C; Briand JP; Hoebeke J; Deniaud A; Brenner C; Rustin P; Edelman L; Rebouillat D; Jacotot E
Cell Death Differ; 2007 Mar; 14(3):422-35. PubMed ID: 16888644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
